Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Top 10 Copper-producing Companies (Updated 2024)

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

Top 10 Countries for Natural Gas Production (Updated 2024)

A State-by-State Guide to Cannabis in Australia

Craig Hemke: Gold's Next Price Target, Key Silver Factors to Watch

Top Stories This Week: Gold Consolidates as Stagflation Risks Rise, Copper Breaks US$10,000

Hydrogen Stocks: 9 Biggest Companies

7 Biggest Lithium-mining Companies

Trending Press Releases

Purepoint Uranium Group Inc. Launches Strategic Drill Program at Turnor Lake Project Targeting the La Rocque Structural Corridor

Material Sale of VMware Cloud Platform

CENTURY LITHIUM ANNOUNCES POSITIVE FEASIBILITY STUDY FOR THE CLAYTON VALLEY LITHIUM PROJECT, NEVADA

Western Copper and Gold Announces Exercise of Participation Right in Full by Rio Tinto

Sona's Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model

Quarterly Activities and Cash Flow Report

More Press Releases
Trending Companies

Jindalee Lithium

JLL:AU

Norfolk Metals

NFL:AU

Rio Silver

RYO:CA

Elixir Energy

EXR:AU
More Companies
Trending Reports

Lithium Outlook for Australia

2024 Uranium Outlook (Updated for Q2)

2024 Gold Outlook Report

2024 Lithium Market Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Moleculin Biotech Inc.

NASDAQ:MBRX
Press Releases

Moleculin Expects to Meet FDA IND Filing Requirements for its Pancreatic Cancer Drug Candidate with Development Work in Australia

Moleculin’s Breakthrough Discovery of a New Molecule for Cancer Treatment Advances to Development Agreement with the University of Iowa

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.

×